Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant formula comments

This article was originally published in The Tan Sheet

Executive Summary

FDA is reopening the comment period for a 1996 proposed rule that recommended changes to infant formula regulations regarding clinical studies and the presence of microorganisms in formula products, according to the July 31 Federal Register. The 1996 comment period first was reopened in May 2003 and several meetings have been held since, the agency notes. In addition, the Institute of Medicine issued a report in March 2004 entitled, "Infant Formula: Evaluating the Safety of New Ingredients," that discussed clinical trials. FDA asks in its current notice whether the agency should require a measure for body composition as an indicator of normal physical growth, and if so, at what measure. According to the FDA, some of the 2003 comments questioned FDA's authority to require a clinical study to measure physical growth. The IoM report, however, concluded that growth studies should "remain the centerpiece" of testing new infant formulas because "the inability of a formula to support growth represents a significant harm to infants"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099607

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel